Data Protection - Perú

Authors

  • Maritza Reátegui Valdiviezo

Keywords:

data protection, Data exclusivity, clinical studies, Pharmaceutical Law, Pharmaceutical products

Abstract

The present article refers to the implementation of the Protection of Testing Data for
pharmaceutical products in the light of the implementation of the FTA signed by Peru
and the United States of America and the application of the definitions given by the
TRIPS for this figure. The national legislation and the applicable treaties are analyzed
as well as the first cases of protection to the new chemical entities given by the regulatory
authority. The successes and drawbacks of the new Testing Data legislation. Their
impact on heath and research issues.

Metrics

PDF views
159
Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 202622
|
HTML views
14
Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20264.0
|

Author Biography

Maritza Reátegui Valdiviezo

Catedrática Universitaria y expositora nacional e internacional en temas de propiedad intelectual y
Derecho Farmacéutico. Es Socia del Estudio Muñiz, Ramírez, Pérez – Taiman & Olaya Abogados

Published

30.11.2019

How to Cite

Reátegui Valdiviezo, M. (2019). Data Protection - Perú. Revista De Derecho, 13(1), 115–146. Retrieved from https://revistas.udep.edu.pe/derecho/article/view/1624

Issue

Section

DOCTRINA NACIONAL